The Effect of Metformin on Liver Lipid Accumulation in Mice Fed a High-fat Diet

Title
The Effect of Metformin on Liver Lipid Accumulation in Mice Fed a High-fat Diet
Author(s)
김종연김윤혜[김윤혜]이윤주김용운박소영도경오정윤영[정윤영]
Keywords
ACTIVATED PROTEIN-KINASE; INSULIN-RESISTANCE; GENE-EXPRESSION; DISEASE; CHOLESTEROL; METABOLISM; SYNTHASE; INFLAMMATION; STEATOSIS; MECHANISM
Issue Date
201004
Publisher
KOREAN SOC APPLIED BIOLOGICAL CHEMISTRY
Citation
JOURNAL OF THE KOREAN SOCIETY FOR APPLIED BIOLOGICAL CHEMISTRY, v.53, no.2, pp.198 - 205
Abstract
Fat accumulation in the liver involves an imbalance in the hepatic uptake of free fatty acids and their metabolism. Fat accumulation in the liver plays a critical role in the initiation of nonalcoholic steatohepatitis, which may progress to liver fibrosis and cirrhosis. The prevention of hepatic fat accumulation, therefore, may be effective therapy for nonalcoholic fatty liver disease. However, the effect of insulin sensitizing drugs on hepatic fat accumulation is still unclear. Here, we show that metformin, the most widely used insulin sensitizer, prevents liver fat accumulation induced by a high-fat diet. Male C57BL/6 mice weighing 18 similar to 20 g were grouped as follows for 8 weeks: mice chow diet, high-fat diet pair-fed control, and high-fat diet with metformin. Triglyceride and total cholesterol levels in plasma and liver were measured. AMP-activated protein kinase activity in liver were determined by Western blot. Expressions of SREBP1c and FAS in the liver were measured using RT-PCR. The high-fat diet increased body weight, abdominal fat mass, fat accumulation in the liver, and plasma total cholesterol, as well as liver triglyceride and total cholesterol levels, but plasma triglyceride levels were unchanged. Metformin decreased each of these measures. The high-fat diet decreased liver AMP-activated protein kinase activity as well as SREBP-1c and FAS expressions, and metformin reversed these changes. In conclusion, a high-fat diet induced visceral obesity and hepatic fat accumulation. Metformin prevented visceral obesity, hepatic fat accumulation, and reduced plasma total and LDL-cholesterol concentrations, potentially through modulating AMP-activated protein kinase activity and the expressions of SREBP-1C and FAS.
URI
http://hdl.handle.net/YU.REPOSITORY/22642http://dx.doi.org/10.3839/jksabc.2010.032
ISSN
1738-2203
Appears in Collections:
의과대학 > 생리학교실 > Articles
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE